单支1.27元的氨茶碱注射液,价格堪比一瓶普通矿泉水,却成为老牌药企新华制药盈利滑坡的缩影。今年以来,新华制药(000756.SZ/0719.HK)创新动作频频,一边推进创新转型与产能升级,1类创新药LXH-12n片启动肺动脉高压临床、利丙双卡因乳膏斩获注册证书,默克合作项目放量叠加现代医药物流项目投用;另一边,2025年三季度报告披露的业绩却亮起红灯——前三季度营业收入67.63亿元,同比微增...
Source Link单支1.27元的氨茶碱注射液,价格堪比一瓶普通矿泉水,却成为老牌药企新华制药盈利滑坡的缩影。今年以来,新华制药(000756.SZ/0719.HK)创新动作频频,一边推进创新转型与产能升级,1类创新药LXH-12n片启动肺动脉高压临床、利丙双卡因乳膏斩获注册证书,默克合作项目放量叠加现代医药物流项目投用;另一边,2025年三季度报告披露的业绩却亮起红灯——前三季度营业收入67.63亿元,同比微增...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.